CGRB Insider Trading Activity and SEC Form 4 Filings
CGRB insider trading summary
No open-market insider purchases or sales of Cougar Biotechnology, Inc. (CGRB) have been reported on SEC Form 4 in the past 12 months.
Latest CGRB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 9, 2009 | Lindsay A Md Rosenwald | 10% Owner | Sell | $429K (10,000 @ $42.90) |
| Jun 9, 2009 | Horizon Biomedical Ventures LLC | 10% Owner | Sell | $429K (10,000 @ $42.90) |
| Feb 21, 2008 | Arie Belldegrun | Director | Buy | $8K (300 @ $26.99) |
| Feb 21, 2008 | Arie Belldegrun | Director | Buy | $127K (4,700 @ $27.00) |
| Dec 18, 2007 | Arie Belldegrun | Director | Buy | $458K (15,000 @ $30.50) |
| Jul 19, 2007 | Thomas Malley | Director | Buy | $175K (8,068 @ $21.75) |
| Jul 18, 2007 | Thomas Malley | Director | Buy | $185K (8,500 @ $21.75) |
| Jul 17, 2007 | Thomas Malley | Director | Buy | $73K (3,350 @ $21.75) |
| Jun 18, 2007 | Arie Belldegrun | Director | Buy | $88K (3,700 @ $23.90) |
| May 8, 2007 | Arie Belldegrun | Director | Buy | $150K (7,100 @ $21.10) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.